AI Wants to be the Future of Drug Discovery

AI Wants to be the Future of Drug Discovery
thedailyupside.com

by Brian Boyle • 26 days ago

Novo Nordisk has expanded its partnership with Valo Health to leverage AI for drug discovery, focusing on treatments for cardiometabolic diseases. Simultaneously, AMD is investing $20 million in Absci to enhance its AI capabilities in drug development, aiming to compete with Nvidia. Both companies emphasize the importance of integrating AI with human data to advance drug discovery, signaling a shift from traditional lab methods to AI-driven processes in the biotech industry.

Summarized in 80 words

Latest AI Tools

More Tech Bytes...